| pubmed-article:1225988 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1225988 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:1225988 | lifeskim:mentions | umls-concept:C0027882 | lld:lifeskim |
| pubmed-article:1225988 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
| pubmed-article:1225988 | lifeskim:mentions | umls-concept:C0599756 | lld:lifeskim |
| pubmed-article:1225988 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:1225988 | pubmed:dateCreated | 1976-8-2 | lld:pubmed |
| pubmed-article:1225988 | pubmed:abstractText | The effects of various doses of 6-hydroxydopamine (6-OHDA) injected into the hypothalamus on DOCA-salt-induced hypertension were studied. The development of hypertension was prevented in the group treated with the highest dose of 6-OHDA, and the onset of hypertension was delayed in a dose-dependent fashion in the groups treated with the lower doses of 6-OHDA. Catecholamine histofluorescence observations showed that the cannula tips placed the drug lateral to the third ventricle. The most prominent change observed was a marked unilateral reduction in the fluorescence of the dopaminergic nerves of the caudate-putamen and in the number of cell bodies in the substantia nigra. These results suggest possible sites of central aminergic control of blood pressure. | lld:pubmed |
| pubmed-article:1225988 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1225988 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1225988 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1225988 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1225988 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1225988 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1225988 | pubmed:issn | 0360-4012 | lld:pubmed |
| pubmed-article:1225988 | pubmed:author | pubmed-author:LORCYGG | lld:pubmed |
| pubmed-article:1225988 | pubmed:author | pubmed-author:JacobowitzD... | lld:pubmed |
| pubmed-article:1225988 | pubmed:author | pubmed-author:RichardsonJ... | lld:pubmed |
| pubmed-article:1225988 | pubmed:author | pubmed-author:LamprechtFF | lld:pubmed |
| pubmed-article:1225988 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1225988 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:1225988 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1225988 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1225988 | pubmed:pagination | 227-34 | lld:pubmed |
| pubmed-article:1225988 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:meshHeading | pubmed-meshheading:1225988-... | lld:pubmed |
| pubmed-article:1225988 | pubmed:year | 1975 | lld:pubmed |
| pubmed-article:1225988 | pubmed:articleTitle | Central adrenergic neurons in DOCA-salt hypertension. | lld:pubmed |
| pubmed-article:1225988 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1225988 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
